AI-generated summary
The authors studied low-level laser therapy (660 nm and 904 nm) applied to the spinal cord of mice with experimental autoimmune encephalomyelitis, a model of multiple sclerosis. They report reduced clinical scores, delayed disease onset, less weight loss, lower nitric oxide levels, fewer inflammatory cells and less demyelination. The study used a mouse model, so its findings may not apply directly to humans.
- Who or what was studied
- Female C57BL/6 mice with experimental autoimmune encephalomyelitis
- Wavelengths
- 660, 904 nm
- Limits stated in the abstract
- The abstract describes an animal study and does not report a total sample size or a human outcome.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 904 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Neuroinflammation, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.